The Pollock siblings and Joseph Hutchinson III proposed multiple changes to prosecutors' statements in outlining the charges ...

In a report released yesterday, Justin Zelin from BTIG maintained a Buy rating on Poseida Therapeutics (PSTX – Research Report), with a ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whether to participate in cancer trials, according to surveys of patients ...

By leveraging the proven efficacy of Trulicity and Viagra in combination with buntanetap, Annovis is expanding its pipeline and advancing its mission to enhance cognition for those suffering from ...

Announced strategic financing with Arena Investors, providing access to up to $59.0 million USD in gross proceeds to Announced positive top-line results from our Phase 2 proof-of-concept clinical ...

Calyx and Invicro businesses officially launched under its new corporate identity, Perceptive. The new name reflects the ...

Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting ...

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the initiation of the sentinel cohort of its Phase 2b clinical trial evaluating Vaxart’s ...

Review: POTENTIAL ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS IN SUBSTANCE USE DISORDER: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS. Image Credit: Designua / Shutterstock A systematic ...

Kevin Meek litigates patent disputes in federal courts across the country, before the US International Trade Commission, and in post-grant ...

The CARTITUDE-4 study found that cilta-cel reduced the risk of death by 45% compared to standard of care in patients with multiple myeloma.

Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis and systemic lupus erythematosus – – Mary Beth ...